External validity of docetaxel triplet trials in advanced gastric cancer: are there patients who still benefit?

BACKGROUND: The purpose of our study was to develop an online calculator to estimate the effect of docetaxel triplets (DPF) in first line of advanced gastric cancer (AGC), and to assess the external validity of docetaxel trials in individual patients. METHODS: The study includes patients with HER2(-...

Descripción completa

Detalles Bibliográficos
Autores principales: Jimenez-Fonseca, Paula, Carmona-Bayonas, Alberto, Martínez de Castro, Eva, Custodio, Ana, Pericay Pijaume, Carles, Hernandez, Raquel, Aguado, Gema, Castro Unanua, Natalia, Cano, Juana María, López, Flora, Garrido, Marcelo, Fernández Montes, Ana, Visa, Laura, Sánchez Cánovas, Manuel, Limón, María Luisa, Martínez Lago, Nieves, Pimentel, Paola, Hurtado, Alicia, Azkárate, Aitor, Longo, Federico, Diez, Marc, Arias-Martinez, Aranzazu, Sauri, Tamara, Martín Carnicero, Alfonso, Mangas, Monserrat, Martín Richard, Marta, Granja, Mónica, Ramchandani, Avinash, Hernández Pérez, Carolina, Cerdá, Paula, Gil-Negrete, Aitziber, Calvo, Mariona, Vidal Tocino, Rosario, Gallego, Javier
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Singapore 2020
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7902567/
https://www.ncbi.nlm.nih.gov/pubmed/32970266
http://dx.doi.org/10.1007/s10120-020-01116-x

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7902567/
https://www.ncbi.nlm.nih.gov/pubmed/32970266
http://dx.doi.org/10.1007/s10120-020-01116-x

Ejemplares similares